Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions!
Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239
There are three major types of bladder cancer and are named on the basis of type of cells become cancerous (malignant). These type are as follows –
• Transitional Cell Carcinoma: Transitional cell carcinoma is also called as urothelial carcinoma. It begins in the urothelial cells of the bladder which are located in the lining the bladder. This is the common type of bladder cancer.
• Squamous Cell Carcinoma: This type of cancer initiates in the squamous cells and it develops in the bladder, following prolonged irritation or infection
• Adenocarcinoma: This type of cancer begins in the secretory cells (glandular) that are located in the lining of bladder. This is very rare type of bladder cancer.
According to the study of American Society of Clinical Oncology (ASCO), urothelial carcinoma accounts for around 90%, squamous cell carcinoma accounts 4% and adenocarcinoma accounts 2% of all bladder cancer. The remaining 4% bladder cancer includes other rare type of bladder cancer viz. sarcoma and small cell anaplastic cancer.
There are different types of treatment followed by doctors, which are mostly dependent on the patient’s preference for treatment and also based on type, possible side effects of the treatment and stage of bladder cancer.
Increasing incidence rate, especially in developed regions fueling growth of bladder cancer therapeutics market
As per stats released by the International Agency for Research on Cancer (IARC), 59% of bladder cancer cases are observed in developed countries, with Belgium reporting the highest number of bladder cancer cases.
As per stats released by Cancer Research UK—a charity involved in cancer research and development—here were around 10,100 new cases reported in the U.K. in 2014. Bladder cancer accounts for around 3% of all new cancer cases reported in the U.K. As per a study by the American Society of Clinical Oncology (ASCO), incidence rate of the disease has decreased by around 12% in the U.K. in the recent past.
According a study by Cancer Research Institute, bladder cancer is more prevalent among men than women. Around 77,000 new cases were diagnosed in the U.S. in 2016, leading to 16,000 deaths. Continuous advancements in clinical research resulted into increased survival rate of people suffering from bladder cancer, which is around 77% observed in last few years. As per the stats of American Cancer Society, bladder cancer accounts for 5% of all new cancer cases in the U.S.
Some are the major reasons behind bladder cancer are unhealthy habits. Smoking is a major cause along with that continuous exposure of industrial chemicals, drinking water with high level of arsenic, family history of bladder cancer, and long-term use of urinary catheters are the other causes of bladder cancer. In Africa and Middle East schistosomiasis and infested water are the leading cause of bladder cancer.
For More Information About This Report @ https://www.coherentmarketinsights.com/ongoing-insight/bladder-cancer-therapeutics-market-239
North America holds major share in the global bladder cancer therapeutics market, followed by Europe due to advanced treatments, developed economy, and easy access to advanced healthcare facilities. The market in APAC region will witness high growth rate in the near future, due to increasing per capita income, developing economy, government initiatives on improving healthcare infrastructure, growing FDI in healthcare, and rapidly increasing aging population. As per stats released by the Department of Industrial Policy and Promotion (DIPP), the healthcare sector in India witness FDI worth US$ 4.09 billion between April 2000 and September 2016. Also, medical tourism in the region is a flourishing business, due to easy access to high-quality low-cost treatment option. According to data released by the India Brand Equity Foundation (IBEF)— a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India—the medical tourism industry in India rakes in US$ 3 billion each year. This creates a highly conducive environment for growth of the bladder cancer therapeutics market in the region.
Conversely, increasing use of generic drugs, high cost of treatment, asymptomatic nature of the disease and fewer pipeline products inhibit growth of the market. As per data released by the American Cancer Society, only one drug received approval from FDA in last three decade.
Global Key Players:
The major companies playing key role in bladder therapeutics market are Sanofi S.A., F. Hoffmann-La Roche AG, Novartis, Pfizer, Eli Lilly and Co., GlaxoSmithKline, Bristol-Myers Squibb, Allergan Inc, AVI Biopharma Inc., and AstraZeneca plc. Some are the major drugs approved by Food and Drug Administration used for the treatment of bladder cancer are Cisplatin, Nivolumab, Thiotepa, Atezolizumab, Doxorubicin Hydrochloride, Opdivo (Nivolumab), Platinol-AQ (Cisplatin), Platinol (Cisplatin), and Tecentriq (Atezolizumab).
Bladder cancer therapeutics market taxonomy:
Global Market by Bladder Cancer Type
• Urothelial Carcinoma
• Squamous Cell Carcinoma
Global Market by Treatment Type
◦ Transurethral bladder tumor resection (TURBT)
◦ Urinary Diversion
◦ Intravesical (local) Chemotherapy
◦ Systemic (whole body) Chemotherapy
◦ Intravesical Therapy
◦ Interferon Therapy
• Radiation Therapy
Global Market by Test Type
• Urine Cytology
• Bladder Ultrasound
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/239
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions! here
News-ID: 1557796 • Views: 356
More Releases from Coherent Market Insights
Sheet Face Masks Market - As Companies Committed for Digital Transformation, the …
Coherent Market Insights has released a new research study on the "Sheet Face Masks Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Sheet Face Masks Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Sheet Face Masks market research report
Lipid Testing Market Insights: 2022, Growing Business Demand and Upcoming Opport …
Coherent Market Insights has released a new research study on the "Lipid Testing Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Lipid Testing Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Lipid Testing market research report is an intelligence
After-sun Products Market - As Companies Committed for Digital Transformation, t …
Coherent Market Insights has released a new research study on the "After-sun Products Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global After-sun Products Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The After-sun Products market research report is an intelligence
Online Retail Market Will Generate Massive Growth 2022-2028 |Amazon Inc., Alibab …
Coherent Market Insights has released a new research study on the "Online Retail Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Online Retail Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Online Retail market research report is an intelligence
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and